American International Group, Inc. Voyager Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.15 - $10.84 $25,811 - $39,132	3,610 Added 22.87%	19,397 $180,000
Q4 2023 Feb 13, 2024	SELL	$6.28 - $8.81 $401 - $563	-64 Reduced 0.4%	15,787 $133,000
Q3 2023 Nov 13, 2023	BUY	$7.55 - $11.25 $4,258 - $6,345	564 Added 3.69%	15,851 $122,000
Q2 2023 Aug 04, 2023	BUY	$6.94 - $13.99 $106,091 - $213,865	15,287 New	15,287 $175,000
Q2 2021 Aug 13, 2021	SELL	$3.94 - $5.44 $59,344 - $81,937	-15,062 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.61 - $9.04 $179 - $352	39 Added 0.26%	15,062 $71,000
Q4 2020 Feb 12, 2021	SELL	$7.15 - $12.28 $3,081 - $5,292	-431 Reduced 2.79%	15,023 $107,000
Q3 2020 Nov 04, 2020	SELL	$10.01 - $13.75 $3,523 - $4,840	-352 Reduced 2.23%	15,454 $165,000
Q2 2020 Aug 12, 2020	BUY	$8.05 - $14.21 $12,195 - $21,528	1,515 Added 10.6%	15,806 $199,000
Q1 2020 May 04, 2020	SELL	$6.8 - $14.66 $5,616 - $12,109	-826 Reduced 5.46%	14,291 $131,000
Q4 2019 Feb 05, 2020	SELL	$12.82 - $16.85 $1,615 - $2,123	-126 Reduced 0.83%	15,117 $211,000
Q3 2019 Nov 08, 2019	SELL	$16.31 - $28.29 $1,745 - $3,027	-107 Reduced 0.7%	15,243 $262,000
Q2 2019 Aug 13, 2019	BUY	$19.18 - $27.88 $32,030 - $46,559	1,670 Added 12.21%	15,350 $418,000
Q1 2019 May 06, 2019	SELL	$8.0 - $19.66 $3,552 - $8,729	-444 Reduced 3.14%	13,680 $262,000
Q4 2018 Feb 13, 2019	SELL	$8.59 - $18.05 $919 - $1,931	-107 Reduced 0.75%	14,124 $133,000
Q3 2018 Nov 09, 2018	BUY	$17.11 - $21.74 $4,380 - $5,565	256 Added 1.83%	14,231 $269,000
Q2 2018 Aug 08, 2018	BUY	$16.76 - $23.92 $51,520 - $73,530	3,074 Added 28.2%	13,975 $273,000
Q1 2018 May 07, 2018	SELL	$16.16 - $31.31 $9,469 - $18,347	-586 Reduced 5.1%	10,901 $205,000
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $21,160 - $44,668	1,726 Added 17.68%	11,487 $191,000
Q3 2017 Nov 09, 2017	BUY	$8.37 - $20.59 $81,699 - $200,978	9,761	9,761 $201,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$31.4 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.7 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$23.2 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.8 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.5 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $228M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account